BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30910348)

  • 1. Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms.
    Guilmette J; Nosé V
    Semin Diagn Pathol; 2019 Jul; 36(4):229-239. PubMed ID: 30910348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic endocrine syndromes].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2023-30. PubMed ID: 3013095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic syndromes: A focus on pathophysiology and supportive care.
    Chung C; Allen E; Umoru G
    Am J Health Syst Pharm; 2022 Nov; 79(22):1988-2000. PubMed ID: 35916756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocrine paraneoplastic syndromes].
    Reisch N; Reincke M
    Internist (Berl); 2018 Feb; 59(2):125-133. PubMed ID: 29387897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraneoplastic endocrine syndromes: diagnosis and management].
    Valdes-Socin H; Niaourou V; Vandeva S; Bosquée L; Beckers A
    Rev Med Suisse; 2009 Aug; 5(214):1668-74. PubMed ID: 19772199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumors.
    Ferone D; Albertelli M
    Thorac Surg Clin; 2014 Aug; 24(3):277-83. PubMed ID: 25065928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cancer-associated paraneoplastic syndromes.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Essop R; Meyerov R; Lemmer J
    SADJ; 2010 Oct; 65(9):424-6. PubMed ID: 21180290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine paraneoplastic syndromes in lung cancer.
    Efthymiou C; Spyratos D; Kontakiotis T
    Hormones (Athens); 2018 Sep; 17(3):351-358. PubMed ID: 29968234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraendocrine syndromes.
    Pierce ST
    Curr Opin Oncol; 1993 Jul; 5(4):639-45. PubMed ID: 8364080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic neurologic manifestations of neuroendocrine tumors.
    Zoccarato M; Grisold W
    Handb Clin Neurol; 2024; 200():397-407. PubMed ID: 38494292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic hormonal syndromes].
    Forga L; Anda E; Martínez de Esteban JP
    An Sist Sanit Navar; 2005; 28(2):213-26. PubMed ID: 16155618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine/metabolic syndromes of cancer.
    Odell WD
    Semin Oncol; 1997 Jun; 24(3):299-317. PubMed ID: 9208886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendorine paraneoplastic syndromes].
    Böhm M; Gellner R
    Hautarzt; 2021 Apr; 72(4):299-306. PubMed ID: 33661337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic syndromes: an approach to diagnosis and treatment.
    Pelosof LC; Gerber DE
    Mayo Clin Proc; 2010 Sep; 85(9):838-54. PubMed ID: 20810794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance.
    Ferlito A; Rinaldo A; Bishop JA; Hunt JL; Vander Poorten V; Williams MD; Triantafyllou A; Devaney KO; Gnepp DR; Kusafuka K; Halmos GB; Westra WH; Takes RP; Thompson LD
    Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):533-6. PubMed ID: 25351497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic endocrine syndromes: clinical picture and laboratory diagnostics].
    Igaz P
    Magy Onkol; 2023 Jun; 67(2):102-105. PubMed ID: 37314070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic syndromes secondary to neuroendocrine tumours.
    Kaltsas G; Androulakis II; de Herder WW; Grossman AB
    Endocr Relat Cancer; 2010 Sep; 17(3):R173-93. PubMed ID: 20530594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of paraneoplastic syndromes in children.
    Ma GM; Chow JS; Taylor GA
    Pediatr Radiol; 2019 Apr; 49(4):534-550. PubMed ID: 30877339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic syndromes: concept and limits. Viewpoint of the internist and the dermatologist].
    Gilsanz García V; Gómez Orbaneja J
    An R Acad Nac Med (Madr); 1985; 102(4):353-84. PubMed ID: 3832962
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M; Nakahara T; Miki M; Igarashi H; Ito T; Furue M
    Eur J Dermatol; 2014; 24(6):702-3. PubMed ID: 25333507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.